Logo image of ESBA

EMPIRE STATE REALTY OP LP-ES (ESBA) Stock Fundamental Analysis

NYSEARCA:ESBA - NYSE Arca - US2921021000 - Currency: USD

8.01  -0.03 (-0.37%)

Fundamental Rating

4

ESBA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. Both the profitability and the financial health of ESBA get a neutral evaluation. Nothing too spectacular is happening here. ESBA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year ESBA was profitable.
ESBA had a positive operating cash flow in the past year.
In multiple years ESBA reported negative net income over the last 5 years.
Each year in the past 5 years ESBA had a positive operating cash flow.
ESBA Yearly Net Income VS EBIT VS OCF VS FCFESBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

ESBA has a better Return On Assets (1.90%) than 66.92% of its industry peers.
Looking at the Return On Equity, with a value of 10.98%, ESBA belongs to the top of the industry, outperforming 91.54% of the companies in the same industry.
The Return On Invested Capital of ESBA (2.83%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ESBA is in line with the industry average of 3.16%.
The 3 year average ROIC (2.32%) for ESBA is below the current ROIC(2.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.9%
ROE 10.98%
ROIC 2.83%
ROA(3y)1.01%
ROA(5y)0.92%
ROE(3y)5.78%
ROE(5y)5.14%
ROIC(3y)2.32%
ROIC(5y)2.29%
ESBA Yearly ROA, ROE, ROICESBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

ESBA has a better Profit Margin (10.84%) than 62.31% of its industry peers.
In the last couple of years the Profit Margin of ESBA has declined.
ESBA has a Operating Margin (19.84%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ESBA has declined.
With a Gross Margin value of 54.16%, ESBA is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
ESBA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.84%
PM (TTM) 10.84%
GM 54.16%
OM growth 3Y23.05%
OM growth 5Y-5.33%
PM growth 3YN/A
PM growth 5Y-7.53%
GM growth 3Y1.23%
GM growth 5Y-0.78%
ESBA Yearly Profit, Operating, Gross MarginsESBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ESBA is destroying value.
Compared to 1 year ago, ESBA has less shares outstanding
The number of shares outstanding for ESBA has been reduced compared to 5 years ago.
ESBA has a better debt/assets ratio than last year.
ESBA Yearly Shares OutstandingESBA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ESBA Yearly Total Debt VS Total AssetsESBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

ESBA has a debt to FCF ratio of 24.05. This is a negative value and a sign of low solvency as ESBA would need 24.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 24.05, ESBA is in the better half of the industry, outperforming 76.15% of the companies in the same industry.
A Debt/Equity ratio of 3.07 is on the high side and indicates that ESBA has dependencies on debt financing.
The Debt to Equity ratio of ESBA (3.07) is worse than 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.07
Debt/FCF 24.05
Altman-Z N/A
ROIC/WACC0.42
WACC6.82%
ESBA Yearly LT Debt VS Equity VS FCFESBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

ESBA has a Current Ratio of 5.01. This indicates that ESBA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.01, ESBA belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
ESBA has a Quick Ratio of 5.01. This indicates that ESBA is financially healthy and has no problem in meeting its short term obligations.
ESBA has a Quick ratio of 5.01. This is amongst the best in the industry. ESBA outperforms 94.62% of its industry peers.
Industry RankSector Rank
Current Ratio 5.01
Quick Ratio 5.01
ESBA Yearly Current Assets VS Current LiabilitesESBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.45% over the past year.
Measured over the past years, ESBA shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.00% on average per year.
Looking at the last year, ESBA shows a small growth in Revenue. The Revenue has grown by 1.72% in the last year.
ESBA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.22% yearly.
EPS 1Y (TTM)37.45%
EPS 3YN/A
EPS 5Y-5%
EPS Q2Q%-28.05%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y6.68%
Revenue growth 5Y0.22%
Sales Q2Q%6.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESBA Yearly Revenue VS EstimatesESBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.70, which means the current valuation is very expensive for ESBA.
Based on the Price/Earnings ratio, ESBA is valued a bit cheaper than 73.08% of the companies in the same industry.
ESBA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.7
Fwd PE N/A
ESBA Price Earnings VS Forward Price EarningsESBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESBA is valued cheaply inside the industry as 95.38% of the companies are valued more expensively.
ESBA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESBA is cheaper than 93.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.28
EV/EBITDA 8.19
ESBA Per share dataESBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.35%, ESBA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.64, ESBA's dividend is way lower than its industry peers. On top of this 88.46% of the companies listed in the same industry pay a better dividend than ESBA!
With a Dividend Yield of 1.35, ESBA pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

ESBA has been paying a dividend for at least 10 years, so it has a reliable track record.
ESBA has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
ESBA Yearly Dividends per shareESBA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

51.56% of the earnings are spent on dividend by ESBA. This is a bit on the high side, but may be sustainable.
DP51.56%
EPS Next 2YN/A
EPS Next 3YN/A
ESBA Yearly Income VS Free CF VS DividendESBA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 50M 100M
ESBA Dividend Payout.ESBA Dividend Payout, showing the Payout Ratio.ESBA Dividend Payout.PayoutRetained Earnings

More info and screens

EMPIRE STATE REALTY OP LP-ES

NYSEARCA:ESBA (7/2/2025, 8:04:00 PM)

8.01

-0.03 (-0.37%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-0.82%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap864.27M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly Dividend0.38
Dividend Growth(5Y)N/A
DP51.56%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.7
Fwd PE N/A
P/S 1.17
P/FCF 9.28
P/OCF 3.72
P/B 1.18
P/tB N/A
EV/EBITDA 8.19
EPS(TTM)0.3
EY3.75%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.86
FCFY10.78%
OCF(TTM)2.15
OCFY26.9%
SpS6.85
BVpS6.77
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.9%
ROE 10.98%
ROCE 3.59%
ROIC 2.83%
ROICexc 3.1%
ROICexgc 3.95%
OM 19.84%
PM (TTM) 10.84%
GM 54.16%
FCFM 12.6%
ROA(3y)1.01%
ROA(5y)0.92%
ROE(3y)5.78%
ROE(5y)5.14%
ROIC(3y)2.32%
ROIC(5y)2.29%
ROICexc(3y)2.53%
ROICexc(5y)2.5%
ROICexgc(3y)3.23%
ROICexgc(5y)3.23%
ROCE(3y)2.94%
ROCE(5y)2.9%
ROICexcg growth 3Y27.14%
ROICexcg growth 5Y-4.6%
ROICexc growth 3Y28.34%
ROICexc growth 5Y-4.52%
OM growth 3Y23.05%
OM growth 5Y-5.33%
PM growth 3YN/A
PM growth 5Y-7.53%
GM growth 3Y1.23%
GM growth 5Y-0.78%
F-Score8
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.07
Debt/FCF 24.05
Debt/EBITDA 6.66
Cap/Depr 73.36%
Cap/Sales 18.84%
Interest Coverage 1.59
Cash Conversion 69.07%
Profit Quality 116.25%
Current Ratio 5.01
Quick Ratio 5.01
Altman-Z N/A
F-Score8
WACC6.82%
ROIC/WACC0.42
Cap/Depr(3y)59.56%
Cap/Depr(5y)78.28%
Cap/Sales(3y)17.15%
Cap/Sales(5y)21.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.45%
EPS 3YN/A
EPS 5Y-5%
EPS Q2Q%-28.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.72%
Revenue growth 3Y6.68%
Revenue growth 5Y0.22%
Sales Q2Q%6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.49%
EBIT growth 3Y31.26%
EBIT growth 5Y-5.13%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.73%
FCF growth 3Y33.48%
FCF growth 5Y20.95%
OCF growth 1Y10.1%
OCF growth 3Y8.45%
OCF growth 5Y-3.58%